USPTO serial 88325889
PACIRA CRYOTECH
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GAGLIARDI, JEANINE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PACIRA CRYOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Analgesics; chemical preparations and reagents for pharmaceutical, medical, and veterinary clinic purposes, namely, pharmaceutical preparations for acute care treatment, namely, for the monitoring and treatment of pain and cancer; pharmaceutical preparations for post-surgical use | ACTIVE | — |
| 010 | Medical device, namely, an injectable cold temperature device for peripheral nerve treatment; Medical device for cryoanalgesic therapy | ACTIVE | — |
| 040 | Custom manufacture of medical goods, namely, drug delivery devices in the nature of implanted or topically applied aggregations of liposomes providing timed-release of encapsulated pharmaceuticals, made to the order or specification of others, for treatment of a wide variety of diseases | ACTIVE | — |
| 042 | Research and development of new surgical products, diagnostic products and medical treatments for others; scientific research and development services; development and engineering services in the field of surgical, diagnostic and therapeutic products; product development; design of new products for others; Design of medical goods for others, namely, drug delivery devices in the nature of implanted or topically applied aggregations of liposomes providing timed-release of encapsulated pharmaceuticals, made to the order or specification of others, for treatment of a wide variety of diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pacira Pharmaceuticals, Inc.
- Other trademarks owned by Pacira Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PACIRA CRYOTECH
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 5, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 5, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 22, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 20, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 20, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 20, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 2, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 2, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 2, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 3, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 9, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 9, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 30, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 16, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 16, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 16, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 16, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 16, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 14, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 22, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 8, 2019 | NWAP | NEW APPLICATION ENTERED | — |